Menu
Home
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Labrish
Nyuuz
Museveni Cheers Ugandan Cancer Breakthrough
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
[QUOTE="Munyaradzi Mafaro, post: 33753, member: 636"] During their Sunday meeting at State House Entebbe, President Museveni praised Dr. Matthias Magoola for obtaining a U.S. patent on cancer treatment. The president promised government backing to help Ugandan vaccines reach global markets. He stressed the need to pass new drug legislation that would allow Uganda's regulatory agency to meet international standards for approving locally made vaccines. The U.S. Patent Office recently published Dr. Magoola's patent for cancer therapy using guided RNA with CRISPR-Cas9 gene editing. His method targets cancer mutations but prevents cells from repairing damaged genes, which destroys cancer cells without harming healthy tissue. Dr. Magoola said this offers new hope for treating all cancers without harsh side effects. His company, Dei Biopharma, has filed over 100 patents for treatments, including HIV, Alzheimer's, malaria, diabetes, and tuberculosis. The firm also created a universal vaccine for foot and mouth disease, which was accepted for patent in January. Experts say Uganda needs more than political support—the country must implement policies, invest in energy, and fund scientists to succeed globally. [/QUOTE]
Insert quotes…
Name
Post reply
Home
Forums
Labrish
Nyuuz
Museveni Cheers Ugandan Cancer Breakthrough
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top